ArticleInternational journal of oncology2018

Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.

Yu-Chen Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.